Monoclonal Antibodies for HIV—Lessons Learned from COVID-19 - Daniel Kuritzkes

Monoclonal Antibodies and its Production

Monoclonal Antibodies for Treatment in HIV - Marina Caskey, MD

HIV Prevention and Monoclonal Antibodies - Myron Cohen, MD

Monoclonal Antibodies for HIV Prevention - Carlos del Rio

Why is HIV resistant to antibody production? - David Baltimore (Cal Tech)

Highly potent anti-HIV antibodies produced using plants

HIV and Monoclonal Antibodies AQA Biology

GCSE Biology - Monoclonal Antibodies #40

HIV Vaccines and Monoclonal Antibodies – What’s Taking So Long and Why

Dr. Brinda Emu Provides Insight into HIV Monoclonal Antibody Ibalizumab

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron S. Cohen, MD, BS

Broadly neutralizing antibodies and their use in HIV research

Challenges and opportunities on the access to future monoclonal antibodies for HIV prevention

Monoclonal Antibodies: Microbiology

Monoclonal Antibodies and Recombinant Antigens production | contract manufacturing

What is the place of the monoclonal antibodies in the clinic | Julià Blanco, PhD

Implementing Monoclonal Antibodies for Treatment and Prevention in RLS - David H. Brown Ripin

Monoclonal antibody production | Hybridoma technology explained

VE-Panel 2C: Research pathway for the use of monoclonal antibodies in HIV prevention.